Foley Earns High Ranking in The American Lawyer’s 2022 Summer Associate Survey

29 September 2022

Foley & Lardner LLP is proud to have ranked No. 11 nationally in The American Lawyer’s 2022 Summer Associate Satisfaction Survey. The firm’s Boston, Chicago, Dallas, Houston, Milwaukee, and Washington, D.C. offices all ranked in the top 10 in their city for overall satisfaction. Foley improved upon its 2021 Summer Associate Survey ranking, moving up from No. 19 to No. 11.

The annual survey from The American Lawyer polled 5,485 summer associates from 75 law firms on their experiences at their firms. Firms are scored based on summer associate ratings in nine categories, including partner access and mentorship, interactions with other associates, interesting legal work, training, and more.

After a remote-only summer associate program in 2020 and a hybrid format in 2021, Foley was thrilled to welcome law students back into the office for its in-person 2022 Summer Associate Program. The program was bigger than ever, comprising 97 first- and second-year law students from 40 different law schools in 18 Foley offices across the country. The firm also expanded its 1L program, welcoming more first-year students to help them accelerate their practical legal experience. More information on Foley’s Summer Associate Program is available here.

Related News

View All Posts

06 September 2024 In the News

Old Employment Law Principles Can Answer New AI Concerns

The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.

04 September 2024 In the News

Nathaniel Lacktman Comments on Prospect of Regressive DEA Stance on Telemedicine Prescribing of Controlled Substances

Foley & Lardner LLP partner Nathaniel Lacktman, chair of firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, offered insight on how providers might prepare if the U.S. Drug Enforcement Agency (DEA) issues regressive regulations on telemedicine prescribing in the Modern Healthcare article, “Specter of strict DEA prescribing rule rattles telehealth sector.”

04 September 2024 In the News

Louis Lehot on Biotech IPOs – 'Biotech could have a great fourth quarter'

Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”